Pinned Tweet
Creo en el principio de la NO AGRESIÓN como el principal y más importante principio moral y base de la libertad. #Libertario #LET
Fernando Biguria retweeted
This is the reference @escardio has used to downgrade CABG in LVEF<35%. In this thread I will explain why their conclusions are flawed. academic.oup.com/eurheartj/a…
Complex multi vessel dz. CABG seems as the best option.
Is the patient operable or is there a contraindication for surgery? Otherwise PCI would be a disservice to the patient.
How to tackle this LAD in a NSTEMI, 70/F. EF 50%. LCX- nondom- diffuse dis. RCA is ecstatic with 40-50% dis.
@DrRajeshG1 @iamritu @nihar_nayak2 @Drakhil_cardio @AgstamSourabh @drvenkat2517 @DrAatish_ @AlainaZameer
Fernando Biguria retweeted
Happy to share our new paper: “Endothelial Injury as a Potential Contributor to Cardiovascular Toxicity in Hematologic Malignancies.”
Grateful to my co-authors for their contributions and collaboration.
mdpi.com/2079-9721/14/9/342
Fernando Biguria retweeted
The only way for a heart surgeon to be relevant in 2026 is to be able to perform well open surgeries. A generation of cardiac surgeons has been deceived by “thought leaders” in being told that their future was hybrid surgery, while they graduated “surgeons” who could not operate
Replying to @bearcat_sherman @georgetolisjr
In 2009 I went back and did a full Vascular fellowship. So I had Cath/wire skills and independent open CT surgery experience. What did that get me? CT programs saying no thanks. “You’re vascular now. So see you.” Only person to prosper in dual work is Roselli at CCF. Real dual.
Fernando Biguria retweeted
1/10 🧵 TAVI in younger, low-risk patients: are we moving faster than the evidence?
TAVI has transformed aortic stenosis treatment. Its rapid expansion into younger patients with long life expectancy demands more than excellent early outcomes:
Our paper calls for caution.
Fernando Biguria retweeted
All banter aside, PCI is a great treatment modality that saves lives daily. Its biggest problem is that it is grossly abused more often than SVGs by operators doing full metal jacket in young patients’ LAD and RCA, significantly reducing the efficacy of an eventual CABG.
Those of us who were lucky enough to personally know and learn from the great Prof. David Taggart, truly know what a great loss the world of coronary surgery has lost today.
My deepest condolences to his family. He will be remembered.
209
Fernando Biguria retweeted
So the editor has agreed to withdraw the paper but more concerning is that there is no communication or insight about how this could have happened, how they could publish a paper without consent of authors and how they did not detect the obvious plagiarism of figures, text and tables from my original paper.
There are three other papers involving other interventional Cardiologists in this journal with the same situation published within a month of each other
I has come to my attention that someone has published a fraudulent publication last month with my name on it.
They have lifted tables, figures and data from a paper i published in 2009 and then made up a study with "CATHTRONIX" using this data
fraudulent paper: ijcrims.com/cissuejune2026.h…
original paper: eurointervention.pcronline.c…
Not only this, they have added all the original authors fraudulently on this plagiarised publication that infringes the copyright of @EuroInterventio .
I understand that this and other similar fraudulent papers have been submitted to the #EDA Egyptian Drug Authority Egypt to licence Cathtronix products. I have no idea whether the manufacturer is aware.
I have written to the journal editor and also to several other well known interventional cardiologists whose work has been similarly plagiarised and find themselves unknowingly on fraudulent papers without their consent to authorship
Thank you to @Hragy for helping me to contact EDA
Fernando Biguria retweeted
Fraud Alert ‼️ 👇
I has come to my attention that someone has published a fraudulent publication last month with my name on it.
They have lifted tables, figures and data from a paper i published in 2009 and then made up a study with "CATHTRONIX" using this data
fraudulent paper: ijcrims.com/cissuejune2026.h…
original paper: eurointervention.pcronline.c…
Not only this, they have added all the original authors fraudulently on this plagiarised publication that infringes the copyright of @EuroInterventio .
I understand that this and other similar fraudulent papers have been submitted to the #EDA Egyptian Drug Authority Egypt to licence Cathtronix products. I have no idea whether the manufacturer is aware.
I have written to the journal editor and also to several other well known interventional cardiologists whose work has been similarly plagiarised and find themselves unknowingly on fraudulent papers without their consent to authorship
Thank you to @Hragy for helping me to contact EDA
Fernando Biguria retweeted
Replying to @STS_CTsurgery
‼️ Disclosure: The co-directors of the @STS_CTsurgery CABG Academy have just coauthored a highly controversial editorial that is critical of #CABG while taking a comparatively favorable view of #PCI 👇
Unfortunate viewpoint co-lead by the EIC of @EACTS_Journals and the head of coronary surgery in @EACTS. It shows lack of scientific insight and their will to destroy CABG. Have the Ugly Facts Been Beautified to Kill a Sensible Hypothesis?…1/n academic.oup.com/eurheartj/a…
Fernando Biguria retweeted
Unfortunate viewpoint co-lead by the EIC of @EACTS_Journals and the head of coronary surgery in @EACTS. It shows lack of scientific insight and their will to destroy CABG. Have the Ugly Facts Been Beautified to Kill a Sensible Hypothesis?…1/n academic.oup.com/eurheartj/a…
Fernando Biguria retweeted
If you are watching the World Cup in any channel other than @Telemundo then you are missing out big time.
Fernando Biguria retweeted
Mean time to redo-TAVI 6 years. That means a 70 year old patient will get TAVI at 70, TAVI in TAVI at 76, TAVI in TAVI in TSVI at 82 (assuming same degeneration rate) and TAVI in TAVI in TAVI in TAVI at 88 ?? Am I the only one seeing this abomination ?
The number of redo-TAVI procedures is expected to rise substantially as indications expand to younger patients with aortic stenosis who are likely to outlive their index transcatheter heart valve. The ReTAVI registry represents the first prospective, multicentre evaluation of redo-TAVI providing systematically collected, core lab-adjudicated data on procedural feasibility and early outcomes. eurointervention.pcronline.c…



























